LPCN 1144 Resolves NAFLD in Hypogonadal Males

Hypogonadism affects hepatic lipid metabolism and is expected to promote nonalcoholic fatty liver disease (NAFLD). The aims of this study were to determine (1) the prevalence of NAFLD in hypogonadal males and (2) the impact of correction of hypogonadism by LPCN 1144 (Lipocine, Inc., Salt Lake City,...

Descripción completa

Detalles Bibliográficos
Autores principales: Albhaisi, Somaya, Kim, Kilyoung, Baker, Jonathan, Chidambaram, Nachiappan, Patel, Mahesh V., Charlton, Michael, Sanyal, Arun J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527694/
https://www.ncbi.nlm.nih.gov/pubmed/33024914
http://dx.doi.org/10.1002/hep4.1571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527694/
https://www.ncbi.nlm.nih.gov/pubmed/33024914
http://dx.doi.org/10.1002/hep4.1571

Ejemplares similares